🇩🇪 Germany Country × Condition
cancer Clinical Trials in Germany
Active clinical trials for cancer with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇩🇪 Germany
Active Trials in Germany (4)
NCT03934957
Recruiting
Hamburg City Health Study - a German Cohort Study
Enrollment
45,000 pts
Country
🇩🇪 Germany
Universitätsklinikum Hamburg-Eppend...
View Trial → NCT03686124 Phase 1, Phase 2
Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Enrollment
375 pts
Country
🇩🇪 Germany
Immatics US, Inc.
View Trial → NCT06253338
Recruiting
Optimization of Radiation Protection Through Genomic Analyses
Enrollment
30 pts
Country
🇩🇪 Germany
University Hospital, Essen
View Trial → NCT05993910
Recruiting
Prospective Hyperthermia Database in Cancer Patients (HT Register)
Enrollment
1,000 pts
Country
🇩🇪 Germany
Pirus Ghadjar
View Trial → Frequently Asked Questions
How many cancer clinical trials are active in Germany?
There are currently 4 active clinical trials for cancer with sites in Germany, of which 4 are actively recruiting patients.
How can I join a cancer clinical trial in Germany?
To join a cancer clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cancer trials in Germany?
Active cancer trials in Germany span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology